Carlo Fallai
University of Milan
DosimeterCancerRadiologySurgeryOncologyRandomized controlled trialStage (cooking)Medical physicsRadiation treatment planningHead and neck cancerChemotherapyBrachytherapyCarcinomaProstate brachytherapyNasopharyngeal carcinomaHigh-Dose Rate BrachytherapyNuclear medicineRadiation therapyMedicineDosimetry
151Publications
20H-index
2,087Citations
Publications 149
Newest
#1Benjamin Lacas (Université Paris-Saclay)H-Index: 10
#2Alexandra Carmel (Université Paris-Saclay)H-Index: 1
Last. Jean-Pierre Pignon (Université Paris-Saclay)H-Index: 47
view all 38 authors...
Abstract Background and purpose The Meta-Analysis of Chemotherapy in squamous cell Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) improved overall survival (OS) in patients without distant metastasis. We report the updated results. Materials and methods Published or unpublished randomized trials including patients with non-metastatic carcinoma randomized between 1965 and 2016 and comparing curative loco-regional treatment (LRT) to LRT + CT or adding another timing...
3 CitationsSource
#1Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 35
#4Johannes Lars Isaksson (IEO: European Institute of Oncology)H-Index: 1
Last. Mauro PalazziH-Index: 1
view all 37 authors...
Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. A questionnaire dealing with the management of p...
2 CitationsSource
#1Anna CavalloH-Index: 7
#2Tiziana RancatiH-Index: 27
Last. E. OrlandiH-Index: 3
view all 18 authors...
Source
#1E. OrlandiH-Index: 3
#2Giuseppina CalaresoH-Index: 15
Last. Marco BolognaH-Index: 6
view all 19 authors...
Source
Source
#1Barbara VischioniH-Index: 14
#2Alfredo MirandolaH-Index: 14
Last. Francesca ValvoH-Index: 15
view all 15 authors...
Source
#2G. InfanteH-Index: 1
Last. E. OrlandiH-Index: 3
view all 15 authors...
Source
Source
#1Rossana IngargiolaH-Index: 2
#2Maria De SantisH-Index: 35
Last. Ester OrlandiH-Index: 22
view all 22 authors...
This study was an open-label, 2-arms, monocentric, randomized clinical trial comparing Xonrid®, a topical medical device, versus standard of care (SOC) in preventing and treating acute radiation dermatitis (ARD) in Head and Neck Cancer (HNC) and Breast Cancer (BC) patients undergoing radiotherapy (RT). Eligible HNC and BC patients were randomized 1:1 to receive Xonrid® + SOC or SOC during RT. Patients were instructed to apply Xonrid® on the irradiated area three times daily, starting on the firs...
Source
Jul 1, 2020 in EMBC (International Conference of the IEEE Engineering in Medicine and Biology Society)
#1Marco Bologna (Polytechnic University of Milan)H-Index: 6
#2Valentina D. A. Corino (Polytechnic University of Milan)H-Index: 17
Last. Luca T. Mainardi (Polytechnic University of Milan)H-Index: 36
view all 16 authors...
The purpose of this study was to establish a methodology and technology for the development of an MRI-based radiomic signature for prognosis of overall survival (OS) in nasopharyngeal cancer from non-endemic areas. The signature was trained using 1072 features extracted from the main tumor in T1-weighted and T2-weighted images of 142 patients. A model with 2 radiomic features was obtained (RAD model). Tumor volume and a signature obtained by training the model on permuted survival data (RADperm ...
Source